We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
+0.52%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$452M
AUM Growth
-$18M
Cap. Flow
+$4.02M
Cap. Flow %
0.89%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$4.02M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$237M 52.51%
18,136,735
– –
RVMD icon
2
Revolution Medicines
RVMD
$43.7B
$90.3M 19.98%
4,577,840
+182,790
+4% +$4.02M
RAPT
3
DELISTED
RAPT Therapeutics
RAPT
$64.5M 14.27%
335,057
– –
TNYA icon
4
Tenaya Therapeutics
TNYA
$163M
$27.3M 6.03%
9,400,290
– –
SRZN icon
5
Surrozen
SRZN
$282M
$18.7M 4.13%
616,542
– –
ORIC icon
6
Oric Pharmaceuticals
ORIC
$1.44B
$11.4M 2.53%
3,568,181
– –
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$2.46M 0.55%
172,373
– –

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q3 2022 Portfolio in Review

As of Q3 2022, Column Group held 7 positions worth $452M, down 3.8% from $470M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Column Group opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group added most to Revolution Medicines in Q3 2022, an estimated $4.02M increase.
  • Column Group's ten largest holdings make up 100% of its $452M portfolio in Q3 2022.
  • Column Group opened 0 new positions and closed 0 in Q3 2022.
  • Column Group's portfolio value fell 3.8% quarter-over-quarter to $452M.

Based on Column Group's 13F filing for Q3 2022, filed 14 Nov 2022.